Evaluation of commercially available Chikungunya Virus Immunoglobulin M detection assays

American Journal of Tropical Medicine and Hygiene

Volumn 95, Issue 1, 2016, Pages 182-192

  Johnson, Barbara W ^a   Goodman, Christin H ^a   Holloway, Kimberly ^b   De Salazar, P Martinez ^c   Valadere, Anne M ^c   Drebot, Michael A ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c CARIBBEAN PUBLIC HEALTH AGENCY   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; DIAGNOSTIC KIT; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ARTICLE; BIOTINYLATION; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE ASSAY KIT; IMMUNOFLUORESCENCE TEST; LIMIT OF DETECTION; NONHUMAN; QUALITY CONTROL; RAPID TEST; SENSITIVITY AND SPECIFICITY; VIRAL DISEASE ELISA KIT; BLOOD; CANADA; CARIBBEAN; CHIKUNGUNYA FEVER; DIAGNOSTIC KIT; IMMUNOLOGY; ISOLATION AND PURIFICATION; PUBLIC HEALTH SERVICE; REPRODUCIBILITY; STANDARDS; UNITED STATES;

ANTIBODIES, VIRAL; CANADA; CARIBBEAN REGION; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIMIT OF DETECTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84977613081     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.16-0013     Document Type: Article

References (38)

1. Powers AM, 2010. Chikungunya. Clin Lab Med 30: 209-219.
2. Powers AM, Roehrig JT, 2011. Alphaviruses. Methods Mol Biol 665: 17-38.
3. Staples JE, Breiman RF, Powers AM, 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 49: 942-948.
4. Staples JE, Shankar MB, Sejvar JJ, Meltzer MI, Fischer M, 2014. Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg 90: 402-409.
5. Kariuki Njenga M, Nderitu L, Ledermann JP, Ndirangu A, Logue CH, Kelly CH, Sang R, Sergon K, Breiman R, Powers AM, 2008. Tracking epidemic chikungunya virus into the Indian Ocean from east Africa. J Gen Virol 89: 2754-2760.
6. Powers AM, Logue CH, 2007. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88: 2363-2377.
7. Sudeep AB, Parashar D, 2008. Chikungunya: an overview. J Bio-sci 33: 443-449.
8. Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M, 2014. Emergence of chikungunya fever on the French side of Saint Martin Island, October to December 2013. Euro Surveill 19: pii 20752.
9. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X, 2014. Chikungunya in the Americas. Lancet 383: 514.
10. Fischer M, Staples JE, Arboviral Diseases Branch, National Center for Emerging, Zoonotic Infectious Diseases, CDC, 2014. Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013-2014. MMWR 63: 500-501.
11. Kuno G, 2015. A re-examination of the history of etiologic confusion between dengue and chikungunya. PLoS Negl Trop Dis 9: e0004101.
12. Sahadeo N, Mohammed H, Allicock OM, Auguste AJ, Widen SG, Badal K, Pulchan K, Foster JE, Weaver SC, Carrington CV, 2015. Molecular characterisation of chikungunya virus infections in Trinidad and comparison of clinical and laboratory features with dengue and other acute febrile cases. PLoS Negl Trop Dis 9: e0004199.
13. WHO, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New edition. Geneva, Switzerland: WHO.
14. Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, Velez JO, Lambert AJ, Campbell GL, 2007. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 13: 764-767.
15. Blacksell SD, Tanganuchitcharnchai A, Jarman RG, Gibbons RV, Paris DH, Bailey MS, Day NP, Premaratna R, Lalloo DG, de Silva HJ, 2011. Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute chikungunya infection. Clin Vaccine Immunol 18: 1773-1775.
16. Prat CM, Flusin O, Panella A, Tenebray B, Lanciotti R, LeparcGoffart I, 2014. Evaluation of commercially available serologic diagnostic tests for chikungunya virus. Emerg Infect Dis 20: 2129-2132.
17. Kosasih H, Widjaja S, Surya E, Hadiwijaya SH, Butarbutar DP, Jaya UA, Nurhayati Alisjahbana B, Williams M, 2012. Evaluation of two IgM rapid immunochromatographic tests during circulation of Asian lineage chikungunya virus. Southeast Asian J Trop Med Public Health 43: 55-61.
18. Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, Kreher P, Niedrig M, 2008. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 149: 175-179.
19. Rianthavorn P, Wuttirattanakowit N, Prianantathavorn K, Limpaphayom N, Theamboonlers A, Poovorawan Y, 2010. Evaluation of a rapid assay for detection of IgM antibodies to chikungunya. Southeast Asian J Trop Med Public Health 41: 92-96.
20. Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A, Leo YS, Tan LK, Ng LC, 2010. Evaluation of chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl Trop Dis 4: e753.
21. Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 1823-1826.
22. Beaty B, Calisher C, Shope R, 1995. Arboviruses. Lennette E, Schmidt N, Lennette D, Lennette E, eds. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. Washington, DC: American Public Health Association, 189-212.
23. Johnson BW, Kosoy O, Wang E, Delorey M, Russell B, Bowen RA, Weaver SC, 2011. Use of sindbis/eastern equine encephalitis chimeric viruses in plaque reduction neutralization tests for arboviral disease diagnostics. Clin Vaccine Immunol 18: 1486-1491.
24. Johnson AJ, Martin DA, Karabatsos N, Roehrig JT, 2000. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 38: 1827-1831.
25. Martin DA, Noga A, Kosoy O, Johnson AJ, Petersen LR, Lanciotti RS, 2004. Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile virus and St. Louis encephalitis virus infections during the 2002 West Nile virus epidemic in the United States. Clin Diagn Lab Immunol 11: 1130-1133.
26. Martin DA, Biggerstaff BJ, Allen B, Johnson AJ, Lanciotti RS, Roehrig JT, 2002. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 9: 544-549.
27. Pongsiri P, Praianantathavorn K, Theamboonlers A, Payungporn S, Poovorawan Y, 2012. Multiplex real-time RT-PCR for detecting chikungunya virus and dengue virus. Asian Pac J Trop Med 5: 342-346.
28. Clarke DH, Casals J, 1958. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7: 561-573.
29. Newcombe RG, 1998. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17: 857-872.
30. Wilson E, 1927. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22: 209-212.
31. Blacksell SD, 2012. Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs? J Biomed Biotechnol 2012: 151967.
32. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Pelegrino JL, Vazquez S, Artsob H, Drebot M, Gubler DJ, Halstead SB, Guzman MG, Margolis HS, Nathanson CM, Rizzo Lic NR, Bessoff KE, Kliks S, Peeling RW, 2009. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis 15: 436-440.
33. Figueiredo ML, Figueiredo LT, 2014. Emerging alphaviruses in the Americas: chikungunya and Mayaro. Rev Soc Bras Med Trop 47: 677-683.
34. Terzian AC, Auguste AJ, Vedovello D, Ferreira MU, da Silva-Nunes M, Speranca MA, Suzuki RB, Juncansen C, Araujo JP Jr, Weaver SC, Nogueira ML, 2015. Isolation and characterization of Mayaro virus from a human in Acre, Brazil. Am J Trop Med Hyg 92: 401-404.
35. Vieira CJ, Silva DJ, Barreto ES, Siqueira CE, Colombo TE, Ozanic K, Schmidt DJ, Drumond BP, Mondini A, Nogueira ML, Bronzoni RV, 2015. Detection of Mayaro virus infections during a dengue outbreak in Mato Grosso, Brazil. Acta Trop 147: 12-16.
36. Zuchi N, Heinen LB, Santos MA, Pereira FC, Slhessarenko RD, 2014. Molecular detection of Mayaro virus during a dengue outbreak in the state of Mato Grosso, Central-West Brazil. Mem Inst Oswaldo Cruz 109: 820-823.
37. Partidos CD, Paykel J, Weger J, Borland EM, Powers AM, Seymour R, Weaver SC, Stinchcomb DT, Osorio JE, 2012. Crossprotective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine. Vaccine 30: 4638-4643.
38. Powers AM, Brault AC, Tesh RB, Weaver SC, 2000. Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 81: 471-479.